• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腔内治疗 TASC II D 型股腘动脉病变在伴有严重肢体缺血的患者。

Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.

机构信息

Department of Vascular and Endovascular Surgery, Santa Marcelina Hospital, São Paulo, Brazil.

Department of Vascular and Endovascular Surgery, Santa Marcelina Hospital, São Paulo, Brazil.

出版信息

J Vasc Surg. 2019 May;69(5):1510-1518. doi: 10.1016/j.jvs.2018.08.176. Epub 2019 Jan 2.

DOI:10.1016/j.jvs.2018.08.176
PMID:30611581
Abstract

OBJECTIVE

The outcomes of endovascular treatment of femoropopliteal atherosclerotic lesions have been improving recently. Although open repair is indicated for class D femoropopliteal lesions based on the TransAtlantic Inter-Society Consensus II (TASC II) document, in some cases, it is reasonable to use the endovascular approach for these lesions. The aim of this study was to retrospectively analyze the technical aspects and outcomes of treating TASC II D femoropopliteal disease with endovascular approaches.

METHODS

In total, 91 procedures between January 2011 and December 2016 were retrospectively analyzed. We collected data corresponding to the technical aspects and outcomes of treatment from an electronic database. Images and videos of all procedures were reviewed. Among the 91 procedures, 70 were for popliteal artery occlusions involving the trifurcation vessels, and 12 were for superficial femoral artery (SFA) occlusions of >20 cm in length; 9 procedures for occlusions meeting both criteria were also performed. The χ test was employed for statistical analyses, and logistic regression analyses were conducted to identify risk factors. Patency, wound healing, and survival were analyzed using the Kaplan-Meier method. Statistical significance was considered at P < .05.

RESULTS

Approximately 44.4% of all patients were male. The mean age was 67.3 ± 20.7 years. Hypertension, diabetes, current smoker, kidney impairment, coronary disease, and cardiac insufficiency were identified in 92.3%, 66.6%, 21.7%, 7.6%, 25.6%, and 62.8% of the patients, respectively. All included patients had critical limb ischemia (11.5%, 84.6%, and 3.8% of cases corresponding to Rutherford categories 4, 5, and 6, respectively). Technical failure was observed in three patients (3.3%). The mean number of stents used was 0.7 ± 0.65 per patient. Primary patency at 30 days, 1 year, 2 years, and 3 years was 91%, 60.1%, 55.7%, and 50.6%, respectively. Limb salvage at 30 days, 1 year, 2 years, 3 years, and 4 years was 95.2%, 82.2%, 76.9%, 71.8%, and 63.7%, respectively. Reinterventions were necessary in 11.1% of the patients. Comparison of curves revealed significant differences in the 60-day primary patency for the SFA and popliteal groups (standard error, <10%; log-rank, P = .039). Analysis of the risk and technical factors affecting primary patency, limb salvage, and overall survival indicated that female sex was associated with poor survival (odds ratio, 8.942; 95% confidence interval, 1.105-72.36) and that the use of stents was associated with high rates of limb loss in the popliteal group (log-rank, P = .033).

CONCLUSIONS

For endovascular treatment of TASC II D femoropopliteal lesions, primary patency was better in patients with popliteal artery occlusions involving the trifurcation vessels than in those with SFA occlusions >20 cm in length. Female sex was associated with the risk of major amputations, and the use of stents in patients with popliteal occlusions was associated with major limb loss.

摘要

目的

最近,股腘动脉粥样硬化病变的血管内治疗结果一直在改善。尽管根据跨大西洋血管内共识 II(TASC II)文件,对于 TASC II D 型股腘病变,开放修复是指征,但在某些情况下,对于这些病变使用血管内方法是合理的。本研究的目的是回顾性分析采用血管内方法治疗 TASC II D 型股腘病变的技术方面和结果。

方法

共回顾分析了 2011 年 1 月至 2016 年 12 月期间进行的 91 例手术。我们从电子数据库中收集了与治疗技术方面和结果相关的数据。回顾了所有手术的图像和视频。91 例手术中,70 例为涉及三分叉血管的腘动脉闭塞,12 例为股浅动脉(SFA)闭塞>20cm;9 例同时符合上述两种标准的闭塞也进行了治疗。采用卡方检验进行统计学分析,采用逻辑回归分析识别风险因素。采用 Kaplan-Meier 方法分析通畅率、伤口愈合和生存率。P<0.05 为差异有统计学意义。

结果

所有患者中约 44.4%为男性,平均年龄为 67.3±20.7 岁。92.3%、66.6%、21.7%、7.6%、25.6%和 62.8%的患者分别患有高血压、糖尿病、当前吸烟者、肾功能不全、冠心病和心功能不全。所有纳入的患者均有严重肢体缺血(Rutherford 分类的 4、5 和 6 级病例分别对应 11.5%、84.6%和 3.8%)。3 例患者(3.3%)出现技术失败。每位患者平均使用 0.7±0.65 个支架。30 天、1 年、2 年和 3 年的初始通畅率分别为 91%、60.1%、55.7%和 50.6%。30 天、1 年、2 年、3 年和 4 年的肢体存活率分别为 95.2%、82.2%、76.9%、71.8%和 63.7%。11.1%的患者需要再次介入治疗。SFA 组和腘动脉组的 60 天初始通畅率曲线比较差异有统计学意义(标准误差,<10%;对数秩检验,P=0.039)。分析影响初始通畅率、肢体存活率和总生存率的风险和技术因素表明,女性与生存风险增加相关(优势比,8.942;95%置信区间,1.105-72.36),而腘动脉组中支架的使用与较高的肢体丧失风险相关(对数秩检验,P=0.033)。

结论

对于 TASC II D 型股腘动脉病变的血管内治疗,涉及三分叉血管的腘动脉闭塞患者的初始通畅率优于股浅动脉闭塞>20cm 的患者。女性与主要截肢风险相关,而在腘动脉闭塞患者中使用支架与主要肢体丧失风险相关。

相似文献

1
Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.腔内治疗 TASC II D 型股腘动脉病变在伴有严重肢体缺血的患者。
J Vasc Surg. 2019 May;69(5):1510-1518. doi: 10.1016/j.jvs.2018.08.176. Epub 2019 Jan 2.
2
Results of primary stent therapy for femoropopliteal peripheral arterial disease at 7 years.股腘外周动脉疾病初次支架治疗7年的结果。
J Vasc Surg. 2016 Dec;64(6):1696-1702. doi: 10.1016/j.jvs.2016.05.073. Epub 2016 Aug 27.
3
Simultaneous Superficial Femoral Artery Angioplasty/Stent Plus Popliteal Distal Bypass for Limb Salvage.同时进行股浅动脉血管成形术/支架置入术加腘动脉远端旁路移植术以挽救肢体
Ann Vasc Surg. 2020 Feb;63:443-449. doi: 10.1016/j.avsg.2019.10.032. Epub 2019 Oct 25.
4
The association of statin therapy with the primary patency of femoral and popliteal artery stents.他汀类药物治疗与股动脉和腘动脉支架原发性通畅率的关系。
J Vasc Surg. 2018 May;67(5):1472-1479. doi: 10.1016/j.jvs.2017.09.022. Epub 2017 Dec 8.
5
Analysis of endovascular therapy for femoropopliteal disease with the Supera stent.使用Supera支架对股腘动脉疾病进行血管内治疗的分析
J Vasc Surg. 2016 Oct;64(4):1002-8. doi: 10.1016/j.jvs.2016.04.053. Epub 2016 Jul 18.
6
Primary stenting for TASC C and D femoropopliteal lesions: one-year results from a multicentric trial on 203 patients.TASC C和D级股腘动脉病变的初次支架置入术:一项针对203例患者的多中心试验的一年结果
J Cardiovasc Surg (Torino). 2018 Jun;59(3):392-404. doi: 10.23736/S0021-9509.16.09282-X. Epub 2016 Jun 7.
7
Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.股腘动脉TASC II D型病变的血管内治疗与旁路手术比较:一项单中心研究
Ann Vasc Surg. 2018 Feb;47:179-187. doi: 10.1016/j.avsg.2017.09.008. Epub 2017 Sep 22.
8
Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.紫杉醇药物洗脱裸金属支架(Zilver PTX)治疗股腘动脉闭塞性疾病的真实世界疗效
Ann Vasc Surg. 2017 Jan;38:90-98. doi: 10.1016/j.avsg.2016.08.006. Epub 2016 Aug 20.
9
Midterm Outcomes After Infrapopliteal Interventions in Patients With Critical Limb Ischemia Based on the TASC II Classification of Below-the-Knee Arteries.基于膝下动脉TASC II分类的严重肢体缺血患者腘下介入治疗的中期结果
J Endovasc Ther. 2017 Jun;24(3):321-330. doi: 10.1177/1526602817704643. Epub 2017 Apr 19.
10
Impact of femoropopliteal endovascular interventions on subsequent open bypass.股腘动脉血管腔内介入治疗对后续开放旁路手术的影响。
J Vasc Surg. 2016 Sep;64(3):623-8. doi: 10.1016/j.jvs.2016.03.467. Epub 2016 Jun 8.

引用本文的文献

1
Construction of prediction models for novel subtypes in patients with arteriosclerosis obliterans undergoing endovascular therapy: an unsupervised machine learning study.构建接受血管内治疗的动脉硬化闭塞症患者新型亚型的预测模型:一项无监督机器学习研究。
J Cardiothorac Surg. 2024 Jun 25;19(1):370. doi: 10.1186/s13019-024-02913-6.
2
Endovascular Revascularization and Outcomes of Critical Limb-Threatening Ischemia in Trinidad and Tobago: The EVENT Pilot Study-Challenges in a Limited-Resource, Caribbean Setting.特立尼达和多巴哥严重肢体缺血的血管内血运重建及预后:EVENT试点研究——资源有限的加勒比地区环境中的挑战
Cardiol Ther. 2023 Sep;12(3):511-524. doi: 10.1007/s40119-023-00322-9. Epub 2023 Jun 17.
3
The Influence of Diabetes Mellitus on the Outcome of Superficial Femoral Artery Recanalization is Debatable.
糖尿病对股浅动脉再通结局的影响存在争议。
Transl Med UniSa. 2020 Feb 20;21:10-18. eCollection 2020 Jan-Apr.